Cargando…
Oral Medicines for Children in the European Paediatric Investigation Plans
INTRODUCTION: Pharmaceutical industry is no longer allowed to develop new medicines for use in adults only, as the 2007 Paediatric Regulation requires children to be considered also. The plans for such paediatric development called Paediatric Investigation Plans (PIPs) are subject to agreement by th...
Autores principales: | van Riet – Nales, Diana A., Römkens, Erwin G. A. W., Saint-Raymond, Agnes, Kozarewicz, Piotr, Schobben, Alfred F. A. M., Egberts, Toine C. G., Rademaker, Carin M. A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4045729/ https://www.ncbi.nlm.nih.gov/pubmed/24897509 http://dx.doi.org/10.1371/journal.pone.0098348 |
Ejemplares similares
-
Safe and effective pharmacotherapy in infants and preschool children: importance of formulation aspects
por: van Riet-Nales, Diana A, et al.
Publicado: (2016) -
Acceptability of different oral formulations in infants and preschool children
por: van Riet-Nales, Diana A, et al.
Publicado: (2013) -
Practical Problems with Medication Use that Older People Experience: A Qualitative Study
por: Notenboom, Kim, et al.
Publicado: (2014) -
Long-Term Melatonin Therapy for Adolescents and Young Adults with Chronic Sleep Onset Insomnia and Late Melatonin Onset: Evaluation of Sleep Quality, Chronotype, and Lifestyle Factors Compared to Age-Related Randomly Selected Population Cohorts
por: Zwart, Tom C., et al.
Publicado: (2018) -
The efficacy of the entire-vial dosing of emicizumab: Real-world evidence on plasma concentrations, bleeds, and drug waste
por: Donners, Anouk A.M.T., et al.
Publicado: (2023)